Trial intelligence / Profile preview

Eptifibatide in diffuse coronary disease undergoing DES

NCT01454440Phase 4Terminated

Sponsor
University of Turin
Start
Oct 2007
Primary completion
Oct 2009
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of eptifibatide in coronary artery disease (CAD), sponsored by University of Turin. Started Oct 2007; status: terminated.

02

Drugs

eptifibatide
03

Conditions

coronary artery disease (CAD)

Beyond the preview

Go deeper on NCT01454440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01454440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call